home / stock / miro / miro news

MIRO News and Press, Miromatrix Medical Inc. From 01/05/22

Stock Information
Company Name: Miromatrix Medical Inc.
Stock Symbol: MIRO
Market: NASDAQ
Website: miromatrix.com
Menu
MIRO MIRO Quote MIRO Short MIRO News MIRO Articles MIRO Message Board
Get MIRO Alerts

News, Short Squeeze, Breakout and More Instantly...
MIRO - Miromatrix Announces Two New Board Members

EDEN PRAIRIE, Minn., Jan. 05, 2022 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients' lives, today announced the expansion of the board and appoin...
MIRO - Miromatrix Submits Pre-IND Request to the FDA for Its External Liver Assist Product to Treat Acute Liver Failure

EDEN PRAIRIE, Minn., Dec. 17, 2021 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients' lives, today announced it has submitted a pre-IND request to...

MIRO - Miromatrix Medical Inc. (MIRO) CEO Jeff Ross On Q3 2022 Results - Earnings Call Transcript

Miromatrix Medical Inc. (MIRO) Q3 2022 Earnings Conference Call November 15, 2021 4:30 PM ET Company Participants Greg Chodaczek - Gilmartin Group Jeff Ross - CEO Brian Niebur - CFO Conference Call Participants Alex Nowak - Craig-Hallum Capital Disclaimer*: This transcript is designed to be u...

MIRO - Miromatrix Medical EPS misses by $0.12

Miromatrix Medical (NASDAQ:MIRO): Q3 GAAP EPS of -$0.25 misses by $0.12. Revenue of $0.1M (flat Y/Y) Press Release For further details see: Miromatrix Medical EPS misses by $0.12

MIRO - Miromatrix Reports Third Quarter 2021 Results

EDEN PRAIRIE, Minn., Nov. 15, 2021 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients' lives, today reported third quarter 2021 financial results. ...

MIRO - Miromatrix to Report Third Quarter 2021 Financial Results

EDEN PRAIRIE, Minn., Oct. 28, 2021 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients' lives, today announced that the Company will report financia...

MIRO - Miromatrix Announces the First Successful Transplant of a Bioengineered Whole Organ in a Large Animal

EDEN PRAIRIE, Minn., Oct. 07, 2021 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients' lives, today announced it has successfully completed the fir...
MIRO - Miromatrix Medical Added to Russell Microcap® Index

EDEN PRAIRIE, Minn., Sept. 20, 2021 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients' lives, today announced that the Company will be added to th...

MIRO - Miromatrix Welcomes Dr. John Barry as Vice President of Research and Development

EDEN PRAIRIE, Minn., Sept. 09, 2021 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients' lives, today announced the hiring of Dr. John Barry as Vice...

MIRO - Miromatrix Announces Key Strategic Investors to Advance the Development of Bioengineered Livers and Kidneys

EDEN PRAIRIE, Minn., Aug. 11, 2021 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save patients' lives and improve quality of life around the world, announced st...
Previous 10 Next 10